Trial Profile
STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Dec 2023
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Tenecteplase (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- Acronyms STREAM-2
- 13 Nov 2023 Primary endpoint has been met. (Number of patients achieving 50 % ST-segment resolution before and after PCI in lead with maximal ST elevation at baseline; % rescue PCI; TIMI flow grades), as perResults presented at the American Heart Association Scientific Sessions 2023
- 13 Nov 2023 Results of 1-year Mortality Follow-up , presented at the American Heart Association Scientific Sessions 2023
- 20 Dec 2022 Planned End Date changed from 1 Nov 2022 to 1 Oct 2023.